AU2001237433A1 - Preparation containing quinoxaline derivatives - Google Patents

Preparation containing quinoxaline derivatives

Info

Publication number
AU2001237433A1
AU2001237433A1 AU2001237433A AU3743301A AU2001237433A1 AU 2001237433 A1 AU2001237433 A1 AU 2001237433A1 AU 2001237433 A AU2001237433 A AU 2001237433A AU 3743301 A AU3743301 A AU 3743301A AU 2001237433 A1 AU2001237433 A1 AU 2001237433A1
Authority
AU
Australia
Prior art keywords
quinoxaline derivatives
preparation containing
containing quinoxaline
derivatives
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237433A
Other languages
English (en)
Inventor
Hans-Jurgen Driller
Michael Kirschbaum
Hans Neunhoeffer
Frank Pflucker
Volker Scholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001237433A1 publication Critical patent/AU2001237433A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
AU2001237433A 2000-03-17 2001-03-06 Preparation containing quinoxaline derivatives Abandoned AU2001237433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10013318A DE10013318A1 (de) 2000-03-17 2000-03-17 Formulierung enthaltend Chinoxalinderivate
DE10013318 2000-03-17
PCT/EP2001/002517 WO2001068047A2 (de) 2000-03-17 2001-03-06 Zubereitung enthaltend chinoxalinderivate

Publications (1)

Publication Number Publication Date
AU2001237433A1 true AU2001237433A1 (en) 2001-09-24

Family

ID=7635310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237433A Abandoned AU2001237433A1 (en) 2000-03-17 2001-03-06 Preparation containing quinoxaline derivatives

Country Status (7)

Country Link
US (1) US20030207886A1 (US20030207886A1-20031106-C00044.png)
EP (1) EP1267819B1 (US20030207886A1-20031106-C00044.png)
JP (1) JP2003526650A (US20030207886A1-20031106-C00044.png)
AT (1) ATE403470T1 (US20030207886A1-20031106-C00044.png)
AU (1) AU2001237433A1 (US20030207886A1-20031106-C00044.png)
DE (2) DE10013318A1 (US20030207886A1-20031106-C00044.png)
WO (1) WO2001068047A2 (US20030207886A1-20031106-C00044.png)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111728A1 (de) * 2001-03-09 2002-09-12 Merck Patent Gmbh UV-Filter
DE10238144A1 (de) * 2002-08-15 2004-02-26 Basf Ag Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
CA2548172A1 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
DE102004007966A1 (de) * 2004-02-18 2005-09-08 Merck Patent Gmbh Topische Zusammensetzung, enthaltend mindestens ein Aryloxim und Bisabolol
CN101595100B (zh) 2007-01-16 2014-06-11 普渡制药公司 作为orl-1配体的杂环取代的哌啶
JP5236297B2 (ja) * 2007-03-30 2013-07-17 富士フイルム株式会社 ヘテロ環化合物
EP3564240B1 (en) * 2007-08-31 2022-04-06 Purdue Pharma L.P. Piperidine intermediates
KR100889839B1 (ko) 2007-09-21 2009-03-20 한국화학연구원 신규 2-치환아미노알킬레닐옥시-3-치환페닐에티닐 퀴녹살린유도체
JP5250289B2 (ja) * 2008-03-31 2013-07-31 富士フイルム株式会社 紫外線吸収剤組成物
JP5244437B2 (ja) * 2008-03-31 2013-07-24 富士フイルム株式会社 紫外線吸収剤組成物
CN101644631B (zh) * 2008-08-06 2012-07-04 北京谊安医疗系统股份有限公司 注射泵故障检测装置
JP2010083980A (ja) * 2008-09-30 2010-04-15 Fujifilm Corp 固体高分子材料
TR201910781T4 (tr) * 2009-06-12 2019-08-21 Abivax Kanser tedavisi için yararlı bileşikler.
US10253020B2 (en) 2009-06-12 2019-04-09 Abivax Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
AU2010289397B2 (en) 2009-09-03 2016-05-26 Bioenergenix Heterocyclic compounds for the inhibition of PASK
JP5604161B2 (ja) * 2010-04-12 2014-10-08 株式会社ファンケル 日焼け止め化粧料
GB201007286D0 (en) 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
GB201020179D0 (en) 2010-11-29 2011-01-12 Astex Therapeutics Ltd New compounds
JP5952829B2 (ja) * 2010-12-23 2016-07-13 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｃｒｔｈ２受容体調節剤としてのキノキサリン類およびアザ−キノキサリン類
WO2012094462A2 (en) 2011-01-05 2012-07-12 Bioenergenix Heterocyclic compounds for the inhibition of pask
CA2828349C (en) 2011-03-02 2019-05-21 John M. Mccall Heterocyclic compounds for the inhibition of pask
US8916561B2 (en) 2011-03-02 2014-12-23 Bioenergenix, Llc Substituted quinoxaline compounds for the inhibition of PASK
AR086744A1 (es) * 2011-06-28 2014-01-22 Nippon Soda Co Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions
GB201118656D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118652D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118675D0 (en) 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
GB201118654D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
RU2638540C1 (ru) 2012-04-24 2017-12-14 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы днк-пк
GB201209609D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201209613D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
EP2757161A1 (en) 2013-01-17 2014-07-23 Splicos miRNA-124 as a biomarker of viral infection
HRP20211855T1 (hr) 2013-03-12 2022-03-04 Vertex Pharmaceuticals Incorporated Inhibitori dnk-pk
GB201307577D0 (en) 2013-04-26 2013-06-12 Astex Therapeutics Ltd New compounds
HRP20211839T1 (hr) 2013-07-05 2022-03-04 Abivax Biciklički spojevi korisni za liječenje bolesti uzrokovanih retrovirusima
PL3424920T3 (pl) 2013-10-17 2020-11-16 Vertex Pharmaceuticals Incorporated Kokryształy (S)-N-metylo-8-(1-((2'-metylo-4’,6'-dideutero-[4,5'-bipirymidyn]-6-ylo)amino)propan-2-ylo)chinolino-4-karboksyamidu i ich deuterowane pochodne jako inhibitory DNA-PK
JP6980385B2 (ja) 2014-03-26 2021-12-15 アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited Ｆｇｆｒ阻害剤とｉｇｆ１ｒ阻害剤の組合せ
HUE053654T2 (hu) 2014-03-26 2021-07-28 Astex Therapeutics Ltd FGFR- és CMET-inhibitorok kombinációi a rák kezelésére
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
EP2974729A1 (en) 2014-07-17 2016-01-20 Abivax Quinoline derivatives for use in the treatment of inflammatory diseases
JOP20200201A1 (ar) 2015-02-10 2017-06-16 Astex Therapeutics Ltd تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
US10478494B2 (en) 2015-04-03 2019-11-19 Astex Therapeutics Ltd FGFR/PD-1 combination therapy for the treatment of cancer
BR112018005637B1 (pt) 2015-09-23 2023-11-28 Janssen Pharmaceutica Nv Compostos derivados de quinoxalina, quinolina e quinazolinona,composições farmacêuticas que os compreende, e uso dos referidos compostos
KR20180052631A (ko) 2015-09-23 2018-05-18 얀센 파마슈티카 엔.브이. 비-헤테로아릴 치환된 1,4-벤조디아제핀 및 암의 치료를 위한 이의 용도
KR20190062485A (ko) 2016-09-27 2019-06-05 버텍스 파마슈티칼스 인코포레이티드 Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법
CN111892597B (zh) * 2020-09-01 2023-07-25 山西天宏达安医药科技有限公司 一种喹喔啉基吡啶并吡嗪类化合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3366668A (en) * 1965-10-23 1968-01-30 Gen Aniline & Film Corp 2, 2', 4'-tri-hydroxy benzophenone esters of dicarboxylic acids
US3862951A (en) * 1971-09-02 1975-01-28 Syva Co 2{40 Quinoldinyl glycerol compounds
FR2350096A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la quinoxaline
DE3309400A1 (de) * 1983-03-16 1984-09-20 Wella Ag 3-amino-tetrahydro-1,3-thiazin-2,4-dione, ihre verwendung sowie diese verbindungen enthaltende hautbehandlungsmittel
US5057594A (en) * 1989-08-17 1991-10-15 Eastman Kodak Company Ultraviolet light-absorbing compounds and sunscreen formulations and polymeric materials containing such compounds or residues thereof
WO1994013647A1 (en) * 1992-12-15 1994-06-23 The Du Pont Merck Pharmaceutical Company (2-quinoxalinyloxy)phenoxypropanoic acids and related derivatives as anticancer agents
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
US5998423A (en) * 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
WO2000061631A1 (en) * 1999-04-12 2000-10-19 Astrazeneca Ab Modified pentapeptide antagonists of the atrial natriuretic peptide clearance receptor
DE10111728A1 (de) * 2001-03-09 2002-09-12 Merck Patent Gmbh UV-Filter
US20050020600A1 (en) * 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists

Also Published As

Publication number Publication date
JP2003526650A (ja) 2003-09-09
WO2001068047A3 (de) 2002-03-07
DE50114194D1 (de) 2008-09-18
EP1267819A2 (de) 2003-01-02
DE10013318A1 (de) 2001-09-20
US20030207886A1 (en) 2003-11-06
WO2001068047A2 (de) 2001-09-20
EP1267819B1 (de) 2008-08-06
ATE403470T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
AU2001237433A1 (en) Preparation containing quinoxaline derivatives
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
AU5057998A (en) Insoluble s-triazine derivatives and their use as uv filters
ATE508116T1 (de) Ionische uv-a-sonnenschutzmittel und zusammensetzungen, die diese enthalten
WO2003068183A8 (en) Sunscreen compositions as well as dihydropyridines and dihydropyranes
MX231178B (es) Mezclas de micropigmentos.
GB2396297B (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
AU2001270554A1 (en) Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
AU2002358653A1 (en) Cosmetic and/or pharmaceutical sunscreen preparations
AU2001230202A1 (en) Formulation for protection against oxidative stress containing benzofuranone derivatives
WO2003063790A3 (en) Additives and products including oligoesters
AU2001240940A1 (en) Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care
WO2003003997A3 (de) Verwendung von hopfen- bzw. hopfen-malz-extrakten in kosmetischen oder dermatologischen zubereitungen
WO2002080878A3 (fr) Produit bronzant et filtrant
AU2003266239A1 (en) Use of diketopiperazine derivatives as photostable uv-filters in cosmetic and pharmaceutical preparations
AU2002347271A1 (en) Cosmetic composition for human skin and hair care
WO2002049597A3 (fr) Compositions cosmetiques antisolaires a base d'un melange synergique de filtres et utilisations
BR9912035A (pt) Composições de filtro solar
MXPA05005170A (es) Gel despigmentante alcoholico acuoso que contiene un derivado fenolico y un retinoide.
WO2005009938A3 (fr) Composés dérivés de dibenzoylméthane, utilisation en tant que filtres solaires photoactivables et compositions cosmétiques les contenant
WO2004041173A3 (en) Compositions for darkening the skin and/or hair
AU4047899A (en) Method for providing dibenzoylmethane derivatives with light stability
AU2001235491A1 (en) Cosmetic and pharmaceutical preparations for treating cellulite
ATE364045T1 (de) Trizyklische chinoxalinderivate als uv-filter
WO2001074320A3 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie